Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common diabetes drug help protect aging brains?

NCT ID NCT07395960

First seen Feb 09, 2026 · Last updated Jun 20, 2026 · Updated 19 times

Summary

This study tests whether metformin, a diabetes drug, can improve mild memory and thinking problems in older adults who are overweight or obese. Fifty-four participants will receive either metformin plus lifestyle advice or lifestyle advice alone for 26 weeks. Researchers will use brain scans and memory tests to see if metformin helps by improving how the brain responds to insulin.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Huadong Hospital, Fudan University

    RECRUITING

    Shanghai, 200040, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

metformin

What this could lead to

If it works, this could point toward a simple, affordable way to slow memory decline in older adults with excess weight.

What could go wrong

This is a small, early-phase study with only 54 participants, so results may not apply widely. Metformin may not improve cognition, and side effects like stomach upset are possible.

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.